• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

伊朗亚兹德地区糖尿病患者启动胰岛素治疗的障碍。

The barriers against initiating insulin therapy among patients with diabetes living in Yazd, Iran.

作者信息

Shafie Pour M R, Sadeghiyeh T, Hadavi M, Besharati M, Bidaki R

机构信息

Department of Internal Medicine, Rafsanjan University of Medical Sciences, Rafsanjan, Iran.

Department of Psychiatry, Research Center of Addiction and Behavioral Sciences, Hahid Sadoughi University of Medical Sciences, Yazd, Iran.

出版信息

Diabetes Metab Syndr Obes. 2019 Aug 7;12:1349-1354. doi: 10.2147/DMSO.S200867. eCollection 2019.

DOI:10.2147/DMSO.S200867
PMID:31496772
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6689560/
Abstract

INTRODUCTION

The decision to start insulin therapy is often difficult. Determining the barriers against insulin therapy initiation can facilitate care and treatment strategies. The aim of this study was to evaluate the barriers against initiating insulin therapy among patients with diabetes living in Yazd, Iran.

METHODS

This descriptive study was conducted on 214 patients referred to the Diabetes Center of Yazd University of Medical Sciences in 2015. Participants were randomly selected, and then they completed the insulin noncompliance questionnaire (20 questions). The percentage of adherence and the factors contributing to nonadherence to insulin therapy were analyzed using descriptive statistics, the Kruskal-Wallis test, and the Mann-Whitney test.

RESULTS

The most prevalent reason for insulin therapy refusal was expecting a new method of diabetes treatment (54.7%), followed by requiring someone else to administer the injection (19.2%), fear of needles, cost, traveling (18.7%), and stress/emotional problems (18.2%). Lack of trust in the physician was the least restrictive reason for nonadherence to insulin therapy.

CONCLUSION

The most common reason given for insulin therapy refusal was the lack of adequate education. Therefore, specialized educational interventions can help minimize barriers and improve patients' outcomes.

摘要

引言

开始胰岛素治疗的决定往往很困难。确定胰岛素治疗起始的障碍有助于制定护理和治疗策略。本研究的目的是评估伊朗亚兹德地区糖尿病患者开始胰岛素治疗的障碍。

方法

本描述性研究于2015年对转诊至亚兹德医科大学糖尿病中心的214名患者进行。参与者被随机选取,然后完成胰岛素治疗依从性问卷(20个问题)。使用描述性统计、Kruskal-Wallis检验和Mann-Whitney检验分析胰岛素治疗的依从率和导致不依从的因素。

结果

拒绝胰岛素治疗最常见的原因是期待新的糖尿病治疗方法(54.7%),其次是需要他人注射(19.2%)、害怕打针、费用、出行(18.7%)以及压力/情绪问题(18.2%)。对医生缺乏信任是胰岛素治疗不依从最不具限制性的原因。

结论

拒绝胰岛素治疗最常见的原因是缺乏充分的教育。因此,专门的教育干预有助于减少障碍并改善患者的治疗效果。

相似文献

1
The barriers against initiating insulin therapy among patients with diabetes living in Yazd, Iran.伊朗亚兹德地区糖尿病患者启动胰岛素治疗的障碍。
Diabetes Metab Syndr Obes. 2019 Aug 7;12:1349-1354. doi: 10.2147/DMSO.S200867. eCollection 2019.
2
Factors affecting the choice of treatment center by infertile couples: A cross-sectional study in Yazd Reproductive Sciences Institute.影响不孕夫妇选择治疗中心的因素:在亚兹德生殖科学研究所进行的一项横断面研究。
Int J Reprod Biomed. 2023 Nov 24;21(10):827-834. doi: 10.18502/ijrm.v21i10.14538. eCollection 2023 Oct.
3
Barriers of Doctors and Patients in Starting Insulin for Type 2 Diabetes Mellitus.2型糖尿病患者起始胰岛素治疗时的医患障碍
Cureus. 2021 Sep 25;13(9):e18263. doi: 10.7759/cureus.18263. eCollection 2021 Sep.
4
Data on insulin therapy refusal among type II diabetes mellitus patients in Mashhad, Iran.伊朗马什哈德II型糖尿病患者拒绝胰岛素治疗的数据。
Data Brief. 2018 May 4;18:2047-2050. doi: 10.1016/j.dib.2018.04.136. eCollection 2018 Jun.
5
Insulin refusal in Iranian patients with poorly controlled type 2 diabetes mellitus.伊朗2型糖尿病控制不佳患者的胰岛素抵抗
Acta Med Iran. 2013 Sep 9;51(8):567-71.
6
Comparing the quality of life in insulin recipient and refusal patients with type 2 diabetes.比较2型糖尿病胰岛素治疗患者与拒绝胰岛素治疗患者的生活质量。
Iran J Nurs Midwifery Res. 2016 Jul-Aug;21(4):351-6. doi: 10.4103/1735-9066.185571.
7
Barriers to initiating insulin therapy in patients with type 2 diabetes mellitus in public-sector primary health care centres in Cape Town.开普敦公立部门初级医疗保健中心中2型糖尿病患者开始胰岛素治疗的障碍
S Afr Med J. 2005 Oct;95(10):798-802.
8
Reason for refusal of insulin therapy among type 2 diabetes mellitus patients in primary care clinic in Bangalore.班加罗尔基层医疗诊所中2型糖尿病患者拒绝胰岛素治疗的原因。
J Family Med Prim Care. 2020 Feb 28;9(2):854-858. doi: 10.4103/jfmpc.jfmpc_973_19. eCollection 2020 Feb.
9
The Barriers to Insulin Therapy Initiation in Type 2 Diabetes Patients: A Study of General Practitioner Perceptions in Huinan Community in South Shanghai.2型糖尿病患者起始胰岛素治疗的障碍:上海市南部惠南社区全科医生认知的研究
Diabetes Metab Syndr Obes. 2024 Jan 24;17:393-405. doi: 10.2147/DMSO.S446349. eCollection 2024.
10
Overcoming patient barriers to initiating insulin therapy in type 2 diabetes mellitus.克服2型糖尿病患者启动胰岛素治疗的障碍。
Clin Cornerstone. 2008;9(2):63-70; discussion 71-3. doi: 10.1016/s1098-3597(09)62041-x.

引用本文的文献

1
Challenges to Lifestyle Medicine for Type 2 Diabetes in Iran: A Synoptic Review.伊朗2型糖尿病生活方式医学面临的挑战:综述
Am J Lifestyle Med. 2023 Apr 3;19(4):534-547. doi: 10.1177/15598276231167787. eCollection 2025 May-Jun.
2
Real world evidence of insulin and biosimilar insulin therapy-Opportunities to improve adherence, outcomes and cost-effectiveness.胰岛素及生物类似物胰岛素治疗的真实世界证据——改善依从性、治疗效果和成本效益的机遇
Diabetes Obes Metab. 2025 Apr 15. doi: 10.1111/dom.16386.
3
Assessment of Adherence to Insulin Injections among Diabetic Patients on Basal-Bolus Regimen in Primary and Secondary Healthcare Centers in Al-Jouf Region of Saudi Arabia; A Descriptive Analysis.沙特阿拉伯朱夫地区基层和二级医疗中心接受基础-餐时胰岛素治疗方案的糖尿病患者胰岛素注射依从性评估;描述性分析
J Clin Med. 2023 May 15;12(10):3474. doi: 10.3390/jcm12103474.
4
Assessing Barriers to Insulin Therapy among Omani Diabetic Patients Attending Three Main Diabetes Clinics in Muscat, Oman.评估阿曼马斯喀特三家主要糖尿病诊所的阿曼糖尿病患者接受胰岛素治疗的障碍。
Sultan Qaboos Univ Med J. 2022 Nov;22(4):525-531. doi: 10.18295/squmj.6.2021.086. Epub 2022 Nov 7.
5
Barriers and Facilitators in Access to Diabetes, Hypertension, and Dyslipidemia Medicines: A Scoping Review.糖尿病、高血压和血脂异常药物获取的障碍与促进因素:一项范围综述
Public Health Rev. 2022 Sep 2;43:1604796. doi: 10.3389/phrs.2022.1604796. eCollection 2022.
6
Impact of patients' beliefs about insulin on acceptance and adherence to insulin therapy: a qualitative study in primary care.患者对胰岛素的认知对胰岛素治疗接受度和依从性的影响:一项初级保健中的定性研究
BMC Prim Care. 2022 Jan 20;23(1):15. doi: 10.1186/s12875-022-01627-9.
7
The prevalence and evidence-based management of needle fear in adults with chronic disease: A scoping review.成人慢性病患者中针恐惧的流行情况和基于证据的管理:范围综述。
PLoS One. 2021 Jun 10;16(6):e0253048. doi: 10.1371/journal.pone.0253048. eCollection 2021.
8
Current Pharmacological Treatment of Type 2 Diabetes Mellitus in Undocumented Migrants: Is It Appropriate for the Phenotype of the Disease?未登记移民 2 型糖尿病的现行药理学治疗:其适合疾病表型吗?
Int J Environ Res Public Health. 2020 Nov 5;17(21):8169. doi: 10.3390/ijerph17218169.

本文引用的文献

1
Factors Affecting Insulin Compliance in Patients with Type 2 Diabetes in South Iran, 2017: We Are Faced with Insulin Phobia.2017年伊朗南部2型糖尿病患者胰岛素治疗依从性的影响因素:我们面临胰岛素恐惧症。
Iran J Med Sci. 2019 May;44(3):204-213.
2
Data on insulin therapy refusal among type II diabetes mellitus patients in Mashhad, Iran.伊朗马什哈德II型糖尿病患者拒绝胰岛素治疗的数据。
Data Brief. 2018 May 4;18:2047-2050. doi: 10.1016/j.dib.2018.04.136. eCollection 2018 Jun.
3
Diabetes in Iran: Prospective Analysis from First Nationwide Diabetes Report of National Program for Prevention and Control of Diabetes (NPPCD-2016).伊朗的糖尿病:来自全国糖尿病预防和控制计划(NPPCD-2016)的首次全国糖尿病报告的前瞻性分析。
Sci Rep. 2017 Oct 18;7(1):13461. doi: 10.1038/s41598-017-13379-z.
4
Psychological Insulin Resistance in Patients with Type 2 Diabetes.2型糖尿病患者的心理性胰岛素抵抗
J Assoc Physicians India. 2015 Jul;63(7):33-9.
5
Evaluation of plasma MMP-8, MMP-9 and TIMP-1 identifies candidate cardiometabolic risk marker in metabolic syndrome: results from double-blinded nested case-control study.评价代谢综合征患者血浆基质金属蛋白酶-8、基质金属蛋白酶-9 和组织金属蛋白酶抑制剂-1,以鉴定候选心血管代谢风险标志物:来自双盲巢式病例对照研究的结果。
Metabolism. 2015 Apr;64(4):527-38. doi: 10.1016/j.metabol.2014.12.009. Epub 2014 Dec 30.
6
Insulin adherence in patients with diabetes: risk factors for injection omission.糖尿病患者的胰岛素依从性:注射遗漏的风险因素。
Prim Care Diabetes. 2014 Dec;8(4):338-45. doi: 10.1016/j.pcd.2014.03.001. Epub 2014 Apr 8.
7
Insulin administration and the impacts of forgetting a dose.胰岛素给药及漏服一剂的影响。
Patient. 2014;7(1):63-71. doi: 10.1007/s40271-013-0029-9.
8
Insulin refusal in Iranian patients with poorly controlled type 2 diabetes mellitus.伊朗2型糖尿病控制不佳患者的胰岛素抵抗
Acta Med Iran. 2013 Sep 9;51(8):567-71.
9
Real-world factors affecting adherence to insulin therapy in patients with Type 1 or Type 2 diabetes mellitus: a systematic review.真实世界中影响 1 型或 2 型糖尿病患者胰岛素治疗依从性的因素:系统评价。
Diabet Med. 2013 May;30(5):512-24. doi: 10.1111/dme.12128.
10
Barriers to insulin progression among patients with type 2 diabetes: a systematic review.2 型糖尿病患者胰岛素治疗进展障碍:系统评价。
Diabetes Educ. 2013 Jan-Feb;39(1):53-65. doi: 10.1177/0145721712467696. Epub 2012 Nov 27.